GENMAB A/S (GMAB)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue Quarterly

0 350M 700M 1.1B Q2 '24: 779M Q2 '25: 925M Q2 '24 Q2 '25

Gross Profit Quarterly

0 300M 600M 900M Q2 '24: 751M Q2 '25: 868M Q2 '24 Q2 '25

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Quarterly

0 150M 300M 450M Q2 '24: 236M Q2 '25: 360M Q2 '24 Q2 '25

Net Income Quarterly

0 150M 300M 450M Q2 '24: 203M Q2 '25: 336M Q2 '24 Q2 '25

Cost of Revenue Quarterly

0 20M 40M 60M Q2 '24: 28M Q2 '25: 57M Q2 '24 Q2 '25

Operating Cash Flow Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Free Cash Flow Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Shares Outstanding Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

EPS TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.